Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed in the record history.
    Difference
    0.1%
    Check dated 2025-11-21T00:47:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Removed the generic notice about government funding and potential delays, including links to cc.nih.gov and opm.gov for operating-status updates.
    Difference
    0.8%
    Check dated 2025-11-13T21:48:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    No substantive changes to the listed study record versions or dates; the screenshots show only minor visual/layout tweaks to the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T12:06:48.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.2.0. This indicates a new version release, but does not alter core content or other important data.
    Difference
    0.3%
    Check dated 2025-10-01T04:50:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-30T03:44:26.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed (minor UI change).
    Difference
    0.8%
    Check dated 2025-09-15T19:31:09.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.